Bristol-Myers Squibb (BMY) Reports In-Line Q2 EPS, Updates FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street rallies as Fed's Waller eases rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Bristol-Myers Squibb Reports Second Quarter Financial Results
July 27, 2017 6:59 AM EDTIncreases Second Quarter Revenues 6% to $5.1 Billion Posts Second Quarter GAAP EPS of $0.56 and Non-GAAP EPS of $0.74 Achieves Important Clinical and Regulatory Milestones in Immuno-Oncology Opdivo Approved in Europe for Advanced Form of Bladder Cancer and Squamous Cell Carcinoma of the Head and Neck Opdivo Application for Previously Treated Hepatocellular Carcinoma Granted Priority Review in the U.S. Yervoy Approved in the U.S. for Pediatric Patients with Metastatic Melanoma... More
